多发性硬化痉挛治疗的研究进展  

Research Progress of Spasm Treatment in Patients with Multiple Sclerosis

作　　者：徐沭晗 钟镝[1] 陈洪苹[1] 范学慧 李国忠[1] XU Shu-han;ZHONG Di;CHEN Hong-ping;FAN Xue-hui;LI Guo-zhong(Department of Neurology,the First Affiliated Hospital of Harbin Medical University,Harbin 150000,China)

机构地区：[1]哈尔滨医科大学附属第一医院神经内科,哈尔滨150000

出　　处：《中国临床神经科学》2021年第4期465-470,共6页Chinese Journal of Clinical Neurosciences

摘　　要：多发性硬化(MS)是中枢神经系统最常见的自身免疫性疾病之一,超过80%的MS患者会出现痉挛症状。作为MS致残的重要因素,痉挛主要出现于该疾病的慢性进展期,严重影响患者的生理功能和日常生活质量,因此针对MS患者痉挛症状的功能评估和治疗尤为重要。文中将对MS患者痉挛的发病机制、常用痉挛评估方法和治疗的相关研究进展作综述。Multiple sclerosis(MS)is one of the most common autoimmune diseases of the central nervous system,and more than 80%of patients with MS have spasms.As an important factor of disability caused by MS,spasm mainly occurs in the chronic progression of the disease,seriously affecting the physiological function and quality of daily life of patients,so the functional evaluation and treatment of spasm in patients with MS is particularly important.The pathogenesis,common evaluation methods and treatment of spasm in patients with MS were reviewed.

关 键 词：多发性硬化 痉挛评估 治疗 

分 类 号：R744.5+1[医药卫生—神经病学与精神病学]